BIOLASE to Introduce Galaxy BioMill(TM) CAD/CAM System

BIOLASE to Introduce Galaxy BioMill(TM) CAD/CAM System 
Most Innovative and Competitively Priced Chair-Side Milling System in
the Market; Galaxy BioMill to Be Fully-Integrated With 3Shapes's
Trios Intra-Oral Scanner 
IRVINE, CA -- (Marketwired) -- 11/11/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading manufacturer and distributor of dental
lasers, and a pioneer in laser surgery in other medical specialties,
today announced that it plans to introduce its Galaxy BioMill CAD/CAM
System at the upcoming Greater New York Dental Meeting, the largest
dental congress and exposition in the United States, which will be
held from November 29 through December 4, 2013.  
The Galaxy BioMill, developed and designed by BIOLASE in conjunction
with imes-icore GmbH in Germany, is a CAD/CAM system for scanning,
designing, milling and finishing crowns, inlays, and veneers in the
dental office in a single appointment. Also termed "chair-side"
milling, the market is currently estimated to have reached 15% market
penetration in the U.S. and, according to independent research, is
one of the fastest growing segments in the dental market. The Galaxy
BioMill System will utilize 3Shape Corporation's Trios fast and
highly accurate intra-oral scanner to capture high resolution
three-dimensional ("3-D") digital images of the teeth and
crown-preparation site, which are then processed through a CAD/CAM
software program to design the dental restoration. The design is then
transferred to the Galaxy BioMill to mill the crown using the latest
in aesthetically pleasing, biological compatible, and long-lasting
tooth colored materials. 
Federico Pignatelli, Chairman and CEO of BIOLASE, explained, "We
believe that the Galaxy BioMill is the final key step in the
completion of our Total Technology Solution. We can now offer a
complete portfolio of unique and standard-of-care changing hard- and
soft-tissue dental lasers, 2-D and 3-D digital radiography, and the
best-in-class CAD/CAM products. With the addition of the Galaxy
BioMill, we can provide a one-stop-shop for dentists for all major
high-tech dental capital equipment investments. With this innovative
approach, we will allow dentists to obtain training, service, and
support of multiple high-tech units from one source only, instead of
multiple s
"Imes-icore is a world leader in milling technology and the BioMill
component of the Galaxy System features unmatched accuracy and has
the flexibility to process virtually all CAD/CAM milling block
materials up to 60mm for size in both wet and dry milling. This
flexibility is further enhanced by features normally only found in
high-end mills used by dental laboratories, such as a 6 position tool
changer with digital tool management, 4 axis processing, and a high
precision 360 degrees  A-axis processing station which provides
all-important vibration-free stability. 
"With its open architecture, the Galaxy BioMill with 3Shape CAD/CAM
software can also provide a cost-effective milling solution for the
many Cadent iTero, 3M Lava, and, of course, 3Shape Trios intra-oral
scanner users who recognize the significant return on investment that
it offers and clinical benefits of adding chair-side milling to their
practices. The Galaxy BioMill System will compete with market leaders
such as the Cerec CAD/CAM System, from Sirona, and the E4D System,
distributed by Henry Schein," concluded Pignatelli. 
Cristoph Stark, Managing Director of Imes-Icore GmbH, said, "We are
very excited about this strong alliance and partnership with BIOLASE
and 3Shape. 3Shape and imes-icore were one of the first partners to
cooperate in creating full dental CAD/CAM solutions on a high level,
and both parties have vast experience and interest for developing
additional chairside functionality. We look forward to expanding our
technology into dental practices with BIOLASE as a very powerful
partner in North America." 
3Shape's General Manager, North American Operations, Henrik
Vestermark, also commented, "3Shape is pleased to play a key part in
the joint development of the Galaxy BioMill System and welcomes the
significant opportunity for increased penetration of the important
North American market that BIOLASE provides us. We have worked
closely with imes-icore for many years and believe that the move to
combining digital scanning with CAD/CAM restorations creates a
paradigm shift in dental care with benefits for dentists and patients
being proven every day." 
About imes-icore
 Imes-icore GmbH is a wholly-owned subsidiary of the
isel-Group and a world leader in milling equipment based in
Eiterfield, Germany. The "imes" stands for "integrated mechanics,
electronics and software" and the "icore" represents "integrated
dental solutions." Imes-icore's mission is to develop highly flexible
dental production systems through global alliances with increasing
efficiency, quality of software, and using innovative materials. For
further information regarding imes-icore, please refer to 
About 3Shape
 3Shape is a Danish company specializing in the
development and marketing of 3-D scanners and CAD/CAM software
solutions designed for the creation, processing, analysis and
management of high-quality 3-D data for application in complex
manufacturing processes. 3Shape envisions the Age of "Full Digital
Dentistry," and its more than 140 developers provide superior
innovation power toward reaching this goal. 3Shape's flexible
solutions empower dental professionals through automation of real
workflows, and its systems are applied in thousands of labs in more
than 90 countries worldwide, putting 3Shape technologies at the peak
of the market in relation to units produced per day by dental
With Trios, 3Shape now brings its vast expertise and innovation power
directly to dentists. 3Shape boosts its first-line distributor
support network with a second-line support force of over 30 in-house
experts placed in 5 support and service centers strategically located
around the globe. 3Shape is a privately-held company headquartered in
Copenhagen, with the market's largest team dedicated to scanner and
software development for the dental segment, based in Denmark and
Ukraine, production facilities in Poland, and Business Development &
Support Offices at several locations in Europe, in North and South
America, and in Asia. For further information regarding 3Shape,
please refer to Visit us on, or view our mobile site on  
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures, and markets innovative lasers in dentistry
and medicine and also markets and distributes high-end 2D and 3D
digital imaging equipment and CAD/CAM intraoral scanners; products
that are focused on technologies that advance the practice of
dentistry and medicine. The Company's proprietary laser products
incorporate approximately 300 patented and patent-pending
technologies designed to provide biologically clinically superior
performance with less pain and faster recovery times. Its innovative
products provide cutting-edge technology at competitive prices to
deliver the best results for dentists and patients. BIOLASE's
principal products are revolutionary dental laser systems that
perform a broad range of dental procedures, including cosmetic and
complex surgical applications, and a full line of dental imaging
equipment. BIOLASE has sold more than 23,900 lasers. Other laser
products under development address ophthalmology and other medica
and consumer markets. 
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at, Facebook at, Twitter at,
Pinterest at, LinkedIn at, Google+ at, Instagram at and YouTube at  
BIOLASE(R), WaterLase(R), and Galaxy BioMill(TM) are registered
trademarks or trademarks of BIOLASE, Inc. 
Trios(R) is a registered trademark of 3Shape A/S LLC and NewTom(TM)
is a trademark of QR S.r.l. Corporation, a wholly-owned subsidiary of
Cefla Capital Services, S.p.A. 
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995
 Statements contained in this press release that refer to
BIOLASE's estimated or anticipated future results or other
non-historical facts are forward-looking statements, as are any
statements in this press release concerning prospects related to
BIOLASE's strategic initiatives, product introductions and
anticipated financial performance. Forward-looking statements can
also be identified through the use of words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
"may," "will," and variations of these words or similar expressions.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect BIOLASE's current
perspective of existing trends and information and speak only as of
the date of this release. Actual results may differ materially from
BIOLASE's current expectations depending upon a number of factors
affecting BIOLASE's business. These factors include, among others,
adverse changes in general economic and market conditions,
competitive factors including but not limited to pricing pressures
and new product introductions, uncertainty of customer acceptance of
new product offerings and market changes, risks associated with
managing the growth of the business, and those other risks and
uncertainties that may be detailed, from time-to-time, in BIOLASE's
reports filed with the SEC. BIOLASE does not undertake any
responsibility to revise or update any forward-looking statements
contained herein.  
Image Available: 
For further information, please contact: 
Michael Porter 
Porter, LeVay & Rose, Inc. 
Press spacebar to pause and continue. Press esc to stop.